+ Add Chrome Extension

Yahoo

News
Feb 19, 2021
2  Likes 0  Comments

About this Deal

Johnson & Johnson announced that Janssen-Cilag International N.V. has submitted for Emergency Use Listing (EUL) to the World Health Organization (WHO) for the investigational single-dose Janssen COVID-19 vaccine candidate. The data package delivered today includes interim efficacy and safety results from the Phase 3 ENSEMBLE clinical trial. The Company's rolling submission of clinical data to WHO is now complete.
What's the matter?

💬 Comments

Thanks! Worked! 👍 🙏 🤩 💕 🥳 🔥 😍
👀 Related Deals